This one-pager highlights a regulatory barrier that limits blood centers’ ability to open new collection sites and respond to patient needs. Under current FDA requirements, adding new sites can take months, delaying access to lifesaving blood products. The document outlines the bipartisan solution in the BLOOD Centers Act (H.R. 5791), which would streamline licensure for new sites operating under existing approvals, improving efficiency while maintaining strong safety standards.
Posted in One-Pagers and FAQs